Design Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
DSGN
CUSIP
25056L103
Type
Equity
Class
COM
Num filers
100
Total reported value, excl. options
$223M
Manager Report Date Value ($000) Shares